CClinicalTrials.gg
Status unknownNCT01208571Updated Aug 30, 2012

The Effect of a Interdisciplinary Alcohol Cessation Intervention

An interventional study of "Booster session" in Alcohol Use Disorders, sponsored by Helse Stavanger HF. Status unknown at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-08-30.

Sponsored by Helse Stavanger HF · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2012), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The effect of alcohol interventions seems to be related to the intensity of the interventions. In this study the investigators will assess the effect of a interdisciplinary "booster session" in primary care, given to patients who were admitted to hospitals with alcohol related conditions, and who were given Brief Intervention before discharge. The booster session is based on a motivational interview.

Read the detailed description

The study is a randomized clinical trial, and aims to recruit 60 X 2 patients. Patients admitted to Stavanger University Hospital with an alcohol contributed condition, and who has been given a brief alcohol intervention may be recruited. Candidates for secondary healthcare related to alcohol misuse will be excluded. The interdisciplinary "booster" session will be given two weeks after discharge, and will be given in the facility of the primary care physician, facilitated by both the physician and an liaison alcohol nurse from Stavanger University Hospital. The intervention is based on motivational interview technique. The primary outcome will be assessed using the Alcohol Use Disorder Identification Test-C, six months after discharge. The outcome assessor will be blinded for the intervention. All outcomes will be collected by telephone interview.

The study aims to start recruiting candidates in October-November 2010, and will stoop recruiting in December 2012 at the latest.

The study was approved by the national ethical comite in August 2011. The results of the study wil be published in international referee based journals.

02

Conditions studied

  • Alcohol Use Disorders

Browse trials for

Keywords

  • Harmful use
  • Hazardous use
  • Dependence
03

In context

Alcoholism

1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.

This study's planned enrollment of 120 is above the median of 87 across 1,371 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

Helse Stavanger HF is the lead sponsor of 93 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Admission with an alcohol related disorder

Exclusion criteria

Exclusion Criteria:

  • Lack of ability to give informed consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Lifestyle counseling

    Other: "Booster session"

  • No intervention
    Treatment as usual

Interventions

  • Other"Booster session"

    Motivational interview

06

What researchers measure

Primary outcomes

  1. Alcohol Use Disorder Identification -C (AUDIT-C)

    Alcohol Use Disorder Identification -C. Dicothomous outcome. More or less than four points for women and five points for men.

    Time frame: 6 months

Secondary outcomes

  1. Timeline followback

    Grams og alcohol pr week.

    Time frame: 6 months

  2. Readmissions

    Readmission to a hospital for an alcohol related and/or a non-alcohol related condition within six months after discharge.

    Time frame: 6 months

  3. Readiness to Change Questionaire (RTCQ)

    Continous variable

    Time frame: 6 months

  4. Quality of Life

    SF 12

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Stavanger University Hospital
    Stavanger, 4011, Norway
    • Kristian Oppdal, MD · Contact · kiop@sus.no · +47 48124947
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 30, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01208571
Lead sponsor
Helse Stavanger HF
Responsible party
Sponsor
First posted
Sep 24, 2010
Start date
Apr 2011
Primary completion
Dec 2012 (estimated)
Completion
Dec 2012 (estimated)
Last update
Aug 30, 2012

Study contacts

Åse Cristiansen, RN
Contact
asci@sus.no
+47 05151
Kristian Oppedal, MD
study chair · Helse Stavanger HF
Sverre Nesvaag, Dr
study director · Helse Stavanger HF

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion